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Almost	  all	  genetic	  risk	  factors	  for	  autism	  spectrum	  disorders	  (ASDs)	  can	  be	  
found	  in	  the	  general	  population,	  but	  the	  effects	  of	  that	  risk	  are	  unclear	  in	  
people	  not	  ascertained	  for	  neuropsychiatric	  symptoms.	  Using	  several	  large	  
ASD	  consortia	  and	  population	  based	  resources	  (total	  n>38,000),	  we	  find	  
genomewide	  genetic	  links	  between	  ASDs	  and	  typical	  variation	  in	  social	  
behavior	  and	  adaptive	  functioning.	  This	  finding	  is	  evidenced	  through	  both	  LD	  
score	  correlation	  and	  de	  novo	  variant	  analysis,	  indicating	  that	  multiple	  types	  
of	  genetic	  risk	  for	  ASDs	  influence	  a	  continuum	  of	  behavioral	  and	  
developmental	  traits,	  the	  severe	  tail	  of	  which	  can	  result	  in	  an	  ASD	  or	  other	  
neuropsychiatric	  disorder	  diagnosis.	  A	  continuum	  model	  should	  inform	  the	  
design	  and	  interpretation	  of	  studies	  of	  neuropsychiatric	  disease	  biology.	  
	  	  Autism	  spectrum	  disorders	  (ASDs)	  are	  a	  group	  of	  neuropsychiatric	  conditions	  defined	  through	  deficits	  in	  social	  communication,	  as	  well	  as	  restricted	  and	  repetitive	  interests.	  Consistent	  with	  traditional	  approaches	  to	  psychiatric	  phenotypes,	  most	  genetic	  studies	  of	  ASDs	  compare	  cases	  to	  controls	  in	  order	  to	  identify	  risk-­‐associated	  variation.	  This	  approach	  has	  been	  highly	  productive—recent	  studies	  have	  linked	  common	  polygenic	  as	  well	  as	  de	  novo	  and	  inherited	  rare	  variation	  to	  ASD	  risk	  1,2.	  Common	  genotyped	  SNPs	  are	  estimated	  to	  account	  for	  at	  least	  20%	  of	  ASD	  liability	  1,3,4.	  Contributing	  de	  novo	  variants	  are	  found	  in	  10-­‐20%	  of	  cases	  but	  de	  
novo	  mutations	  collectively	  explain	  less	  than	  5%	  of	  overall	  ASD	  liability	  1,5,6.	  	  	  	  Almost	  all	  genetic	  risk	  factors	  for	  ASDs	  can	  be	  found	  in	  unaffected	  individuals.	  For	  example,	  most	  people	  who	  carry	  a	  16p11.2	  deletion,	  the	  most	  common	  large	  mutational	  risk	  factor	  for	  ASDs,	  do	  not	  meet	  criteria	  for	  an	  ASD	  diagnosis	  7.	  Across	  healthy	  populations	  there	  is	  also	  significant	  variability	  in	  capacity	  for	  social	  interaction	  and	  social	  communication	  8.	  While	  such	  phenotypic	  variation	  is	  well	  established,	  the	  genetic	  relationship	  between	  neuropsychiatric	  disorders	  and	  typical	  social	  and	  behavioral	  variation	  remains	  unclear.	  From	  the	  first	  published	  descriptions	  of	  ASDs,	  clinical	  and	  epidemiologic	  reports	  have	  commonly	  noted	  subthreshold	  traits	  of	  autism	  in	  the	  family	  members	  of	  many	  diagnosed	  individuals	  9,10.	  Twin	  and	  family	  studies	  have	  suggested	  that	  those	  similarities	  are	  at	  least	  in	  part	  inherited	  and	  also	  suggest	  that	  traits	  and	  the	  diagnosis	  are	  correlated	  genetically	  11-­‐13,	  but	  the	  correlation	  has	  yet	  to	  be	  estimated	  using	  measured	  genetic	  data.	  	  We	  examined	  the	  association	  between	  genetic	  risk	  for	  ASDs	  and	  social	  and	  behavioral	  variation	  in	  the	  general	  population,	  and	  examined	  the	  model	  through	  which	  genetic	  risk	  for	  ASDs	  is	  conferred.	  Traditional	  categorical	  psychiatric	  diagnoses	  (e.g.,	  yes/no	  ASD)	  ignore	  the	  possibility	  of	  intermediate	  outcomes,	  long	  known	  to	  be	  relevant	  to	  phenotypes	  like	  intellectual	  disability	  and	  IQ	  that	  are	  more	  easily	  quantified.	  Several	  studies	  have	  now	  associated	  neuropsychiatric	  disease	  associated	  CNVs	  with	  cognitive	  or	  educational	  differences	  in	  the	  general	  population	  14,15.	  De	  novo	  deletions	  at	  16p11.2	  were	  recently	  reported	  to	  confer	  a	  quantitative	  effect	  on	  intelligence	  (an	  average	  two	  standard	  deviation	  reduction	  from	  mean	  IQ	  of	  
the	  parents),	  rather	  than	  creating	  risk	  for	  categorical	  yes/no	  intellectual	  disability	  16.	  The	  extent	  to	  which	  such	  patterns	  extend	  to	  social	  and	  behavioral	  traits	  is	  unknown	  and	  could	  substantially	  influence:	  1)	  the	  design	  and	  interpretation	  of	  biological	  studies	  of	  ASDs	  and	  other	  severe	  mental	  illnesses,	  as	  well	  as	  2)	  the	  designation	  of	  therapeutic	  treatment	  thresholds.	  	  We	  aimed	  to	  resolve	  this	  question	  using	  multiple	  categories	  of	  genetic	  variation	  that	  create	  risk	  for	  ASDs—common,	  inherited	  alleles	  as	  well	  as	  rare,	  de	  novo	  variants.	  	  	  
The	  genetic	  correlation	  between	  ASDs	  and	  typical	  variation	  in	  social	  and	  
communication	  ability	  	  Like	  nearly	  all	  common	  diseases,	  common	  variant	  risk	  for	  ASDs	  is	  distributed	  across	  the	  genome,	  with	  many	  thousands	  of	  contributing	  loci	  of	  small	  effect	  1,3.	  The	  cumulative	  contribution	  of	  common	  SNPs	  to	  ASD	  risk	  (SNP	  heritability17)	  has	  been	  estimated	  using	  several	  methods,	  most	  recently	  and	  efficiently	  via	  LD	  score	  regression.	  LD	  score	  regression	  makes	  use	  of	  GWAS	  summary	  statistics	  to	  estimate	  SNP	  heritability	  4.	  The	  method	  can	  also	  be	  used	  to	  estimate	  the	  correlation	  between	  common	  variant	  influences	  on	  two	  phenotypes	  (genetic	  correlation)	  18.	  As	  LD	  score	  correlation	  requires	  only	  GWAS	  summary	  statistics,	  genetic	  correlations	  can	  be	  estimated	  between	  distinct	  data	  sets	  and	  cohorts.	  	  We	  used	  three	  data	  sets	  to	  examine	  the	  common	  variant	  association	  between	  ASDs	  and	  social	  and	  communication	  difficulties	  in	  the	  general	  population	  (Table	  S1).	  First,	  traits	  of	  social	  and	  communication	  impairment	  were	  measured	  using	  the	  Social	  and	  Communication	  Disorders	  Checklist	  (SCDC)	  in	  the	  Avon	  Longitudinal	  Study	  of	  Parents	  and	  Children	  (ALSPAC),	  a	  general	  population	  cohort	  born	  in	  1991-­‐1992	  in	  Bristol,	  United	  Kingdom	  19,20.	  	  The	  SCDC	  is	  a	  parent-­‐rated	  quantitative	  measure	  of	  social	  communication	  impairment	  that	  is	  continuously	  distributed	  and	  has	  been	  extensively	  studied	  21-­‐23.	  There	  is	  substantial	  trait	  overlap	  between	  the	  SCDC	  and	  canonical	  ASD	  symptomology	  (e.g.	  “Not	  aware	  of	  other	  people’s	  feelings”)	  and	  children	  with	  ASDs	  have	  very	  high	  average	  scores	  (indicating	  many	  difficulties)	  on	  the	  SCDC	  21.	  The	  measure	  does	  not	  include	  items	  on	  restricted	  and	  repetitive	  interests.	  For	  the	  purposes	  of	  this	  project,	  we	  used	  summary	  statistics	  from	  a	  published	  GWAS	  of	  the	  SCDC,	  administered	  when	  the	  children	  were	  8	  years	  old	  (n=5,628)	  23.	  The	  SNP	  heritability	  of	  the	  SCDC	  was	  0.17	  (s.e.=0.09)	  using	  LD	  score	  regression,	  similar	  to	  the	  estimate	  derived	  from	  residual	  maximum	  likelihood	  using	  the	  software	  package	  GCTA	  (h2g=0.24,	  s.e.=0.07;	  n=5,204)	  23.	  	  We	  correlated	  the	  genetic	  influences	  on	  the	  SCDC	  with	  those	  on	  diagnosed	  ASDs	  using	  ASD	  data	  from	  two	  large	  consortium	  efforts.	  The	  Psychiatric	  Genomics	  Consortium	  autism	  group	  (PGC-­‐ASD)	  has	  completed	  a	  GWAS	  of	  5,305	  ASD	  cases	  and	  5,305	  pseudocontrols	  constructed	  from	  untransmitted	  parental	  chromosomes	  (see	  Online	  Methods).	  Summary	  statistics	  from	  that	  GWAS	  are	  publicly	  available	  through	  the	  PGC	  website	  (URLs:	  PGC).	  As	  a	  replication	  set,	  we	  recently	  completed	  an	  independent	  ASD	  case-­‐control	  GWAS	  with	  7,783	  ASD	  cases	  and	  11,359	  controls	  from	  the	  Danish	  iPSYCH	  project	  (iPSYCH-­‐ASD;	  Online	  Methods).	  Using	  LD	  score	  
regression,	  we	  estimated	  that	  the	  liability-­‐scale	  SNP	  heritability	  of	  PGC-­‐ASD	  was	  0.23	  (s.e.=0.03;	  assumed	  population	  prevalence	  1%),	  suggesting	  that	  approximately	  one	  quarter	  of	  ASD	  liability	  reflects	  common	  genotyped	  variation.	  The	  estimated	  liability-­‐scale	  SNP	  heritability	  of	  iPSYCH-­‐ASDs	  was	  0.14	  (se=0.03;	  assumed	  population	  prevalence	  1%).	  The	  genetic	  correlation	  between	  PGC-­‐ASD	  and	  iPSYCH-­‐ASD	  was	  0.74(se=0.07;	  p<1e-­‐20),	  indicating	  similar	  common,	  polygenic	  architecture	  between	  ASDs	  diagnosed	  primarily	  in	  the	  United	  States	  and	  Denmark.	  	  	  
Figure	  1.	  The	  genetic	  correlation	  between	  ASDs	  and	  pediatric	  	  social	  and	  communication	  difficulties	  in	  the	  general	  population	  	  
	  	   	  	  	  	  	  	  	  	  	  The	  estimated	  genetic	  correlations	  between	  the	  SCDC	  in	  ALSPAC	  and	  the	  two	  ASD	  GWAS	  data	  sets	  are	  shown	  in	  Figure	  1.	  The	  estimated	  genetic	  correlation	  between	  PGC-­‐ASD	  and	  the	  SCDC	  was	  0.27	  (s.e.=	  0.13,	  p=0.006),	  suggesting	  that	  approximately	  one	  quarter	  of	  the	  genetic	  influences	  on	  ASDs	  share	  that	  influence	  with	  the	  SCDC.	  The	  estimated	  genetic	  correlation	  between	  iPSYCH-­‐ASD	  and	  the	  SCDC	  was	  similar	  (rg=0.30;	  s.e.=0.10;	  p=0.002),	  evidencing	  substantial	  and	  replicable	  etiologic	  overlap	  between	  ASDs	  and	  typical	  variation	  in	  social	  and	  communication	  ability	  in	  childhood.	  The	  estimated	  genetic	  correlations	  between	  ASDs	  and	  the	  SCDC	  meet	  or	  exceed	  those	  previously	  estimated	  between	  PGC	  ASD	  and	  each	  of	  PGC	  schizophrenia,	  PGC	  bipolar	  disorder,	  and	  PGC	  major	  depressive	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Note:	  Genetic	  correlations	  are	  shown	  +/-­‐	  one	  standard	  error;	  p-­‐values	  indicate	  probability	  with	  which	  true	  genetic	  correlation	  is	  zero;	  PGC=	  Psychiatric	  Genomics	  Consortium;	  ASD=	  Autism	  Spectrum	  Disorders;	  iPSYCH=	  iPSYCH-­‐SSI-­‐Broad	  Autism	  project;	  SCZ=schizophrenia;	  MDD=major	  depressive	  disorder;	  BPD=	  bipolar	  disorder.	  Genetic	  correlations	  were	  estimated	  using	  constrained	  intercept	  LD	  score	  correlation	  .	  The	  correlations	  between	  PGC-­‐ASD	  and	  each	  of	  PGC-­‐SCZ,	  PGC-­‐MDD,	  and	  PGC-­‐BPD	  are	  modified	  from	  Bulik-­‐Sullivan	  and	  Finucane	  et	  al.	  (in	  press).	  	  
disorder	  as	  shown	  in	  Figure	  1.	  This	  suggests	  that	  ASDs	  are	  at	  least	  as	  strongly	  associated	  with	  social	  and	  communication	  trait	  variation	  in	  the	  population	  as	  they	  are	  several	  other	  categorically	  diagnosed	  psychiatric	  disorders.	  The	  observed	  genetic	  correlation	  between	  ASDs	  and	  the	  SCDC	  is	  similar	  to	  that	  estimated	  between	  type	  2	  diabetes	  and	  obesity,	  as	  well	  as	  other	  phenotypes	  that	  are	  strongly	  associated	  epidemiologically	  (Bulik-­‐Sullivan	  and	  Finucane,	  2015).	  Many	  behavioral	  and	  cognitive	  features	  are	  captured	  in	  an	  ASD	  diagnosis:	  social	  communication	  impairment,	  restricted	  and	  repetitive	  interests,	  functional	  impairments,	  and	  often	  co-­‐occurring	  phenotypes	  that	  increase	  probability	  of	  diagnosis	  (e.g.	  intellectual	  disability,	  hyperactivity).	  The	  SCDC	  captures	  only	  traits	  of	  social	  and	  communication	  impairment,	  and	  the	  genetic	  association	  between	  ASDs	  and	  ASD	  traits	  may	  be	  stronger	  if	  more	  dimensions	  of	  the	  ASD	  phenotype	  were	  included	  in	  the	  traits	  measure.	  Supplemental	  analyses	  suggest	  that	  the	  estimated	  ASD-­‐SCDC	  correlations	  are	  not	  driven	  by	  a	  negative	  association	  between	  ASDs	  and	  IQ	  (Table	  S2).	  
	  
The	  continuum	  of	  behavioral	  and	  developmental	  outcomes	  associated	  with	  de	  novo	  
variation	  	  We	  next	  aimed	  to	  examine	  whether	  de	  novo	  variant	  data	  similarly	  gives	  evidence	  of	  a	  genetic	  relationship	  between	  ASDs	  and	  a	  continuum	  of	  behavioral	  outcomes	  in	  the	  population.	  The	  Simons	  Simplex	  Collection	  (SSC)	  is	  a	  sample	  of	  over	  2,800	  individuals	  with	  ASDs	  and	  their	  nuclear	  family	  members,	  with	  extensive	  data	  on	  unaffected	  siblings	  24.	  To	  our	  knowledge,	  the	  SSC	  unaffected	  siblings	  are	  currently	  the	  only	  deeply	  phenotyped	  control	  sample	  with	  de	  novo	  variant	  information	  available.	  The	  Vineland	  Scales	  of	  Adaptive	  Behavior	  (Vineland)	  was	  used	  in	  the	  sequenced	  SSC	  cases	  (n=2,497)	  and	  sibling	  controls	  (n=1,861).	  The	  Vineland	  captures	  parent-­‐rated	  variation	  in	  social,	  communication,	  and	  daily	  living	  skills,	  and	  normalizes	  those	  abilities	  to	  a	  mean	  of	  100	  and	  standard	  deviation	  of	  15	  in	  the	  population,	  corrected	  for	  age	  25.	  On	  average,	  individuals	  with	  ASDs	  have	  mean	  Vineland	  scores	  approximately	  two	  standard	  deviations	  below	  the	  mean	  (SSC	  case	  mean	  =	  73.3;	  s.d.	  =	  12.17),	  consistent	  with	  the	  social	  and	  communication	  impairments	  definitional	  to	  the	  diagnosis.	  The	  distribution	  of	  the	  Vineland	  overlaps	  between	  cases	  and	  controls,	  as	  shown	  in	  Figure	  2a.	  	  
	   	  
Figure	  2a.	  The	  distribution	  of	  Vineland	  scores	  overlaps	  between	  	  SSC	  cases	  and	  controls	  	  
	   	  	  	  	  	  	  We	  examined	  the	  association	  between	  Vineland	  scores	  and	  de	  novo	  variant	  burden	  in	  individuals	  with	  and	  without	  ASDs.	  Our	  previous	  work	  demonstrated	  genotype	  to	  phenotype	  relationships	  using	  variant	  classes	  that	  are	  strongly	  associated	  with	  ASD	  risk	  26;	  subsequently	  these	  analyses	  focused	  on:	  1)	  de	  novo	  loss	  of	  function	  (LoF)	  variants	  and	  2)	  de	  novo	  missense	  variants	  predicted	  to	  be	  damaging	  by	  the	  variant	  annotation	  program	  PolyPhen2	  and	  occurring	  in	  a	  gene	  known	  to	  be	  intolerant	  of	  heterozygous	  missense	  variation	  (DCM)	  27,28.	  We	  found	  that	  variants	  in	  one	  of	  these	  two	  categories	  can	  be	  found	  in	  22.1%	  of	  SSC	  cases	  and	  13.2%	  of	  SSC	  unaffected	  siblings	  (LoF+DCM	  RR=1.68;	  p=1.8e-­‐11;	  online	  methods).	  To	  enhance	  signal,	  we	  further	  filtered	  this	  list	  to	  remove	  de	  novo	  variants	  that	  were	  also	  seen	  in	  adult	  individuals	  in	  the	  Exome	  Aggregation	  Consortium	  (ExAC)	  resource	  (URLs:	  ExAC)	  29.	  The	  ExAC	  database	  includes	  60,706	  exomes.	  Variants	  absent	  from	  that	  reference	  panel,	  which	  is	  a	  proxy	  for	  standing	  variation	  in	  the	  human	  population,	  are	  more	  likely	  to	  be	  deleterious.	  For	  example,	  18.3%	  of	  the	  de	  novo	  LoF	  and	  DCM	  variants	  in	  the	  SSC	  are	  found	  in	  ExAC	  and,	  once	  those	  are	  removed,	  the	  relative	  de	  novo	  LoF+DCM	  burden	  in	  cases	  increases	  (LoF+DCM	  not	  in	  ExAC	  RR=1.91;	  p=7.6e-­‐15).	  	  	  The	  natural	  association	  between	  a)	  de	  novo	  LoF+DCM	  variants	  not	  seen	  in	  ExAC	  and	  b)	  Vineland	  score	  in	  SSC	  cases	  and	  controls	  is	  shown	  in	  Figure	  2b.	  The	  LoF+DCM	  rate	  is	  predicted	  linearly	  by	  functional	  impairment	  in	  both	  cases	  (p=0.008)	  and	  
Note:	  SSC=	  Simons	  Simplex	  Collection.	  The	  Vineland	  Composite	  Standard	  Score	  is	  normed,	  across	  ages,	  at	  mean	  100,	  standard	  deviation	  (SD)	  15	  in	  the	  general	  population.	  The	  SSC	  case	  mean	  (73.3,	  SD=12.2)	  is	  significantly	  lower	  than	  the	  SSC	  control	  mean	  (103.0,	  SD=11.3,	  p<1e-­‐20).	  	  
controls	  (p=0.0002)	  using	  poisson	  regression,	  controlling	  for	  sex.	  Cases	  and	  controls	  with	  equivalent	  quantitative	  levels	  of	  functional	  impairment,	  a	  key	  component	  of	  all	  psychiatric	  diagnoses,	  are	  highly	  similar	  with	  regard	  to	  de	  novo	  variant	  burden,	  suggesting	  that	  the	  current	  categorical	  clinical	  threshold	  is	  largely	  arbitrary	  with	  regard	  to	  the	  social	  and	  communication	  impairments	  captured	  by	  the	  Vineland.	  The	  strength	  of	  the	  association	  between	  LoF+DCM	  burden	  and	  case	  status	  (at	  p=7.6e-­‐15	  without	  controlling	  for	  Vineland	  scores),	  is	  only	  nominally	  significant	  after	  Vineland	  score	  is	  controlled	  for	  (p=0.05).	  The	  associations	  are	  weaker	  but	  similar	  without	  the	  ExAC	  filter	  (Figure	  S1).	  	  	  
Figure	  2b.	  De	  novo	  variation	  influences	  a	  continuum	  of	  functional	  outcomes	  in	  ASD	  cases	  and	  controls	  	  
	   	  	  	  	  	  These	  data	  strongly	  suggest	  that	  genetic	  influences	  on	  ASD	  risk	  –	  both	  inherited	  and	  
de	  novo—	  influence	  typical	  variation	  in	  the	  population	  in	  social	  and	  communication	  ability.	  They	  also	  link	  clinically	  significant	  problems	  to	  impairments	  that	  are	  less	  likely	  to	  be	  ascertained.	  The	  results	  have	  significant	  implications	  for	  genetic	  models	  of	  neuropsychiatric	  disorder	  risk.	  It	  is	  likely	  that	  inherited	  liability	  to	  ASDs	  is	  reflected	  in	  the	  behavioral	  traits	  of	  some	  affected	  individuals’	  family	  members.	  This	  links	  genetic	  and	  phenotypic	  burden	  in	  an	  intuitively	  consistent	  fashion	  with	  complex,	  and	  continuously	  distributed,	  polygenic	  disease	  risk.	  	  For	  traits	  such	  as	  height,	  it	  is	  simple	  to	  conceptualize	  a	  model	  in	  which	  tall	  parents,	  (e.g.	  two	  standard	  deviations	  above	  the	  mean)	  are	  more	  likely	  to	  have	  a	  child	  that	  is	  very	  tall	  (e.g.	  three	  
Note:	  Natural	  (loess)	  association	  shown	  for	  both	  cases	  and	  controls;	  p-­‐values	  derived	  from	  poisson	  regression;	  LoF=	  Loss	  of	  Function;	  DCM	  =	  probably	  damaging	  constrained	  missense;	  ExAC=	  Exome	  Aggregation	  Consortium.	  	  
standard	  deviations	  above	  the	  mean).	  Historically	  this	  has	  been	  more	  complicated	  in	  neuropsychiatric	  disorders.	  	  Despite	  extensive	  evidence,	  some	  have	  even	  questioned	  the	  role	  of	  inheritance	  given	  that	  the	  parents	  of	  individuals	  with	  ASDs	  or	  schizophrenia	  rarely	  carry	  a	  diagnosis	  themselves.	  These	  results	  suggest	  that	  familiality	  should	  be	  studied	  in	  a	  manner	  beyond	  a	  count	  of	  categorically	  affected	  family	  members,	  and	  that	  trait	  variation	  in	  controls	  can	  provide	  insight	  into	  the	  underlying	  etiology	  of	  severe	  neurodevelopmental	  and	  psychiatric	  disorders.	  The	  behavioral	  influence	  of	  de	  novo	  and	  inherited	  genetic	  risk	  for	  ASDs	  can	  be	  quantified,	  and	  studies	  assessing	  continuous	  trait	  variation	  are	  likely	  better	  equipped	  to	  examine	  the	  phenotypic	  correlates	  of	  neuropsychiatric	  disease	  risk.	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Methods	  	  The	  datasets	  used	  in	  these	  analyses	  are	  summarized	  in	  Supplementary	  Table	  1.	  	  
LD	  Score	  genetic	  correlation	  analyses	  	  Genetic	  correlation	  quantifies	  the	  extent	  to	  which	  two	  phenotypes	  share	  genetic	  etiology.	  A	  genetic	  correlation	  of	  one	  suggests	  all	  influences	  are	  shared;	  a	  genetic	  correlation	  of	  zero	  suggests	  the	  phenotypes	  are	  genetically	  independent.	  SNP-­‐based	  genetic	  correlations	  have	  traditionally	  been	  estimated	  using	  data	  sets	  with	  individual-­‐level	  genotype	  and	  phenotype	  data.	  A	  new	  method,	  LD	  Score	  correlation,	  allows	  one	  to	  estimate	  genetic	  relationships	  using	  SNP	  data	  when	  the	  contributing	  data	  sets	  are	  siloed	  18.	  Requiring	  only	  GWAS	  summary	  statistics,	  the	  method	  uses	  linkage	  disequilibrium	  (LD)	  patterns	  to	  estimate	  genetic	  correlations.	  The	  resulting	  correlations	  are	  highly	  similar	  to	  those	  derived	  from	  residual	  maximum	  likelihood	  (e.g.,	  as	  implemented	  in	  GCTA	  or	  BOLT-­‐REML	  17,30)	  and	  Haseman-­‐Elston	  regression	  (URLs:	  Haseman-­‐Elston).	  LD	  Score	  regression	  is	  implemented	  in	  the	  free	  and	  open	  source	  software	  package	  LDSC	  (URLs:	  LDSC).	  	  We	  estimated	  the	  genetic	  association	  between	  diagnosed	  ASDs	  and	  traits	  of	  social	  and	  communication	  impairment	  in	  the	  general	  population	  using	  LD	  score	  correlation.	  Traits	  of	  social	  and	  communication	  impairment	  were	  measured	  using	  the	  Social	  and	  Communication	  Disorders	  Checklist	  (SCDC)	  in	  the	  Avon	  Longitudinal	  Study	  of	  Parents	  and	  Children	  (ALSPAC).	  ALSPAC	  is	  a	  population-­‐based,	  longitudinal	  cohort	  study	  that	  initially	  recruited	  14,541	  pregnancies	  in	  Bristol,	  United	  Kingdom	  with	  expected	  dates	  of	  delivery	  between	  April	  1,	  1991	  and	  December	  31,	  1992.	  All	  women	  in	  the	  study	  area	  with	  expected	  delivery	  dates	  in	  that	  time	  frame	  were	  recruited	  for	  participation	  19,20.	  Ethical	  approval	  was	  obtained	  from	  the	  ALSPAC	  Law-­‐and-­‐Ethics	  Committee	  (IRB00003312)	  and	  the	  Local	  Research	  Ethics	  Committees,	  and	  written	  informed	  consent	  was	  provided	  by	  all	  parents.	  The	  study	  website	  contains	  details	  of	  all	  available	  data	  (URLS:	  ALSPAC).	  The	  GWAS	  of	  the	  SCDC	  in	  ALSPAC,	  from	  which	  we	  obtained	  the	  SCDC	  summary	  statistics,	  has	  already	  been	  published	  23.	  Exome	  sequencing	  data	  from	  trios	  is	  not	  available	  in	  ALSPAC.	  	  The	  SCDC	  is	  a	  12-­‐item	  parent-­‐rated	  scale	  that	  counts	  traits	  of	  social	  and	  communication	  impairment	  quantitatively.	  Each	  question	  has	  a	  0,	  1,	  or	  2	  response	  option;	  the	  subsequent	  range	  of	  total	  scores	  is	  0-­‐24.	  Individuals	  with	  diagnosed	  ASDs,	  on	  average,	  have	  very	  high	  scores	  on	  the	  SCDC,	  consistent	  with	  the	  disorders’	  definitional	  social	  and	  communication	  impairment	  21.	  As	  described	  in	  the	  SCDC	  GWAS,	  the	  SCDC	  was	  used	  at	  multiple	  time	  points	  in	  ALSPAC	  23.	  The	  SCDC	  is	  stable	  over	  time	  22	  and	  individual	  scores	  over	  time	  are	  genetically	  correlated	  23.	  To	  reduce	  multiple	  testing,	  we	  used	  the	  age	  8	  SCDC	  data	  as	  childhood	  autistic	  traits	  are	  well	  studied,	  and	  have	  been	  linked	  to	  diagnosed	  ASDs	  through	  twin	  studies	  11,12.	  We	  also	  focused	  on	  the	  age	  8	  data	  as	  it	  maximizes	  SCDC	  sample	  size	  (n=	  5,628),	  and	  accordingly	  maximizes	  the	  power	  of	  the	  correlation	  tests.	  	  
The	  ASD	  case-­‐control	  GWAS	  summary	  statistics	  come	  from	  the	  PGC	  Autism	  (PGC-­‐ASD)	  group	  and	  the	  iPSYCH-­‐SSI-­‐Broad	  Autism	  group	  (iPSYCH-­‐ASD).	  The	  PGC-­‐ASD	  summary	  statistics	  were	  generated	  using	  publically	  available	  data	  from	  a	  meta-­‐analysis	  of	  5,305	  ASD	  diagnosed	  cases	  of	  ASD	  and	  5,305	  pseudocontrols	  of	  European	  descent	  (URLS:	  PGC).	  The	  pseudocontrol	  methodology	  used	  by	  the	  PGC	  Autism	  group,	  and	  the	  PGC	  GWAS	  analytic	  pipeline,	  have	  been	  reported	  on	  extensively	  3,31.	  Pseudocontrols	  are	  built	  using	  the	  untransmitted	  alleles	  from	  each	  parent	  at	  each	  locus.	  The	  subsequent	  GWAS	  is	  immune	  to	  population	  stratification	  as	  the	  pseudocontrols	  are	  ancestrally	  matched	  to	  the	  cases.	  LD	  score	  correlations	  have	  already	  been	  estimated	  using	  these	  data,	  as	  described	  in	  Bulik-­‐Sullivan	  and	  Finucane18.	  In	  Figure	  1,	  we	  highlight	  a	  subset	  of	  the	  correlations	  from	  that	  manuscript,	  specifically	  those	  associating	  PGC-­‐ASD	  with	  publically	  available	  summary	  statistics	  from	  PGC	  schizophrenia,	  PGC	  bipolar	  disorder,	  and	  PGC	  major	  depressive	  disorder	  (URLS:	  PGC).	  	  The	  iPSYCH-­‐ASD	  data	  are	  from	  a	  new	  population	  based	  case-­‐control	  ASD	  sample	  derived	  from	  the	  Danish	  Neonatal	  Screening	  Biobank	  hosted	  by	  Statens	  Serum	  Institut,	  comprising	  dried	  bloodspots	  (Guthrie	  cards)	  from	  all	  individuals	  born	  in	  Denmark	  since	  1981.	  The	  samples	  can	  be	  linked	  to	  the	  Danish	  register	  system,	  including	  the	  Danish	  Psychiatric	  Central	  Register.	  DNA	  extracted	  from	  the	  bloodspots	  can	  be	  successfully	  amplified	  and	  employed	  in	  GWAS	  32,33.	  The	  iPSYCH-­‐ASD	  project	  aims	  to	  genotype	  all	  Danish	  individuals	  with	  an	  available	  bloodspot	  and	  an	  ASD	  diagnosis	  in	  their	  medical	  record	  (ICD	  codes	  F84.0,	  F84.1,	  F84.5,	  F84.8,	  and	  F84.9).	  This	  study	  has	  been	  approved	  by	  the	  Danish	  research	  ethical	  committee	  system.	  This	  analysis	  employs	  the	  iPSYCH-­‐ASD	  data	  generated	  to	  date,	  specifically	  the	  first	  10	  genotyping	  waves	  of	  that	  collection	  which	  contain	  7,783	  ASD	  cases	  and	  11,359	  controls.	  All	  individuals	  in	  the	  sample	  were	  born	  between	  1981	  and	  2005.	  Genotyping	  was	  performed	  at	  the	  Broad	  Institute.	  The	  data	  were	  cleaned	  and	  analyzed	  using	  the	  same	  analysis	  pipeline	  described	  in	  Ripke	  et	  al.	  2014	  and	  other	  previous	  PGC	  GWAS	  publications.	  	  The	  GWAS	  summary	  statistics	  used	  for	  the	  secondary	  genetic	  correlation	  analyses	  are	  published	  and	  publicly	  available.	  Summary	  statistics	  from	  a	  GWAS	  of	  child	  full	  scale	  IQ	  have	  been	  made	  public	  by	  Benyamin	  et	  al.	  2014,	  and	  were	  used	  in	  Bulik-­‐Sullivan	  and	  Finucane	  et	  al.	  18	  to	  estimate	  a	  genetic	  association	  between	  PGC-­‐ASD	  and	  IQ	  in	  the	  general	  population.	  More	  than	  forty	  percent	  of	  contributing	  individuals	  in	  the	  Benyamin	  GWAS	  were	  from	  the	  ALSPAC	  cohort	  (mean	  age	  9	  years).	  We	  used	  LD	  score	  correlation	  to	  similarly	  estimate	  a	  genetic	  association	  between	  iPSYCH-­‐ASD	  and	  general	  population	  full	  scale	  IQ	  in	  childhood.	  	  Each	  of	  the	  genetic	  correlation	  estimates	  were	  obtained	  using	  constrained	  intercept	  cross-­‐trait	  LD	  Score	  regression,	  which	  yields	  much	  lower	  standard	  errors	  (by	  ~30%)	  than	  unconstrained	  intercept	  LD	  Score	  regression	  18.	  Unlike	  unconstrained	  intercept	  LD	  Score	  regression,	  constrained	  intercept	  LD	  Score	  regression	  can	  give	  biased	  estimates	  of	  genetic	  correlation	  if	  the	  two	  studies	  have	  either	  (a)	  hidden	  sample	  overlap	  or	  (b)	  shared	  population	  stratification.	  We	  can	  rule	  out	  both	  of	  these	  
concerns	  in	  the	  present	  study,	  because	  the	  PGC-­‐ASD	  sample	  is	  family-­‐based	  (case-­‐pseudocontrol),	  and	  does	  not	  have	  case	  or	  control	  overlap	  with	  any	  other	  PGC	  analyses.	  The	  iPSYCH-­‐ASD	  and	  ALSPAC	  samples	  do	  not	  contain	  any	  cases	  or	  pseudocontrols	  that	  were	  used	  in	  PGC-­‐ASD.	  In	  addition,	  case-­‐pseudocontrol	  analyses	  are	  immune	  to	  confounding	  from	  population	  stratification,	  so	  it	  is	  not	  possible	  for	  genetic	  correlation	  estimates	  to	  be	  biased	  by	  population	  stratification	  when	  at	  least	  one	  of	  the	  studies	  used	  a	  case-­‐pseudocontrol	  design.	  As	  a	  robustness	  check,	  we	  verified	  that	  the	  point	  estimates	  of	  genetic	  correlation	  obtained	  with	  unconstrained	  intercept	  LD	  Score	  regression	  are	  similar	  to	  the	  constrained	  intercept	  results	  presented	  in	  Figure	  1	  (although	  the	  standard	  errors	  are	  higher,	  due	  to	  the	  lower	  statistical	  efficiency	  of	  unconstrained	  intercept	  LD	  Score	  regression).	  These	  results	  are	  presented	  in	  Supplementary	  Table	  3.	  	  
De	  novo	  variant	  analyses	  	  The	  Simons	  Simplex	  Collection	  (SSC)	  resource	  is	  unique	  in	  its	  combination	  of	  detailed	  phenotypic	  and	  genotypic	  characterizations.	  The	  SSC	  ascertained	  over	  2800	  individuals	  with	  ASDs	  and	  their	  nuclear	  family	  members,	  restricting	  recruitment	  to	  families	  in	  which	  no	  other	  cases	  of	  ASD	  have	  been	  diagnosed	  out	  to	  the	  level	  of	  first	  cousins.	  Families	  were	  also	  excluded	  in	  the	  event	  of	  intellectual	  disability	  in	  a	  sibling	  or	  a	  history	  of	  parental	  schizophrenia	  24.	  To	  our	  knowledge,	  the	  SSC	  siblings	  currently	  constitute	  the	  most	  deeply	  phenotyped	  control	  sample	  with	  available	  de	  
novo	  variant	  information.	  We	  used	  those	  data	  to	  examine	  the	  relationship	  between	  
de	  novo	  variant	  burden	  and	  phenotypic	  variation	  in	  the	  SSC,	  in	  both	  siblings	  (n=1,861)	  and	  probands	  (n=2,497).	  	  	  We	  limited	  the	  analysis	  to	  de	  novo	  variant	  classes	  that	  are	  strongly	  associated	  with	  ASD	  risk,	  specifically	  loss	  of	  function	  mutations	  (LoF)	  and	  probably	  damaging	  missense	  mutations	  found	  in	  constrained	  genes	  (DCM).	  LoF	  mutations	  include	  frameshift,	  splice	  site,	  and	  nonsense	  mutations.	  DCM	  mutations	  include	  variants	  that	  are	  a)	  predicted	  to	  be	  damaging	  by	  PolyPhen2	  and	  b)	  occurring	  in	  a	  gene	  known	  to	  be	  intolerant	  of	  heterozygous	  missense	  variation	  27,28.	  In	  the	  SSC,	  LoF	  mutations	  are	  found	  in	  8.9%	  of	  controls	  and	  15.0%	  of	  cases;	  DCM	  mutations	  are	  found	  in	  4.3%	  of	  controls	  and	  7.1%	  of	  cases.	  Restricting	  the	  classes	  of	  de	  novo	  variants	  analyzed	  increases	  the	  probability	  of	  association	  to	  case	  status	  as	  well	  as	  to	  phenotypic	  variation	  within	  cases	  26.	  Synonymous	  variants,	  for	  example,	  are	  associated	  with	  neither	  case	  status	  (p=0.23)	  nor	  phenotypic	  variation	  in	  IQ	  (p=0.87)	  or	  Vineland	  scores	  (p=0.91)	  in	  SSC	  cases.	  To	  increase	  signal,	  we	  further	  filtered	  observed	  de	  
novo	  variants	  on	  their	  presence/absence	  in	  the	  publically	  available	  Exome	  Aggregation	  Consortium	  database	  (ExAC;	  URLS:	  ExAC).	  The	  ExAC	  database	  contains	  jointly	  called	  exomes	  from	  60,706	  adult	  individuals,	  recruited	  for	  an	  array	  of	  exome	  sequencing	  studies.	  These	  individual	  exomes	  form	  a	  reference	  panel	  of	  consistently	  processed	  human	  exonic	  variation,	  with	  particular	  utility	  towards	  the	  consideration	  of	  rare	  variants.	  Just	  as	  selection	  reduces	  the	  probability	  with	  which	  LoF	  variants	  will	  be	  seen	  in	  genes	  with	  low	  tolerance	  for	  functional	  disruption	  27,	  reference	  genomes	  will	  be	  less	  likely	  to	  contain	  variants	  that	  create	  strong	  risk	  for	  
reproductively	  deleterious	  phenotypes	  like	  ASDs.	  In	  other	  words,	  one	  expects	  that	  
de	  novo	  variants	  not	  seen	  in	  60,706	  reference	  exomes	  will	  be,	  on	  average,	  more	  deleterious.	  We	  considered	  an	  SSC	  de	  novo	  variant	  recurrent	  if	  a	  variant	  with	  the	  same	  chromosome,	  position,	  reference	  allele,	  and	  alternate	  allele	  was	  seen	  in	  ExAC.	  After	  filtering	  out	  the	  variants	  seen	  in	  ExaC,	  the	  LoF+DCM	  rate	  was	  19.0%	  in	  cases	  and	  9.9%	  in	  controls.	  	  	  We	  have	  previously	  associated	  de	  novo	  variant	  burden	  with	  variation	  in	  case	  IQ	  and	  other	  measures	  of	  case	  severity,	  including	  the	  Vineland	  Scales	  of	  Adaptive	  Behavior	  (Vineland),	  in	  the	  SSC	  26.	  IQ	  was	  not	  measured	  in	  SSC	  siblings,	  however	  the	  Vineland	  was	  used	  in	  a	  manner	  consistent	  with	  its	  use	  in	  cases.	  The	  Vineland	  assesses	  overall	  adaptive	  functioning,	  with	  subscales	  assessing	  1)	  social	  and	  2)	  communication	  ability,	  as	  well	  as	  3)	  daily	  living	  skills.	  The	  Vineland	  is	  commonly	  used	  as	  one	  measure	  of	  case	  severity	  in	  ASD,	  though	  its	  social	  and	  communication	  subscales	  are	  not	  designed	  to	  capture	  canonical	  autism-­‐like	  symptomology.	  In	  this	  analysis,	  we	  used	  Poisson	  regression,	  in	  both	  cases	  and	  controls,	  to	  associate	  Vineland	  scores	  with	  de	  novo	  variant	  burden.	  Sex	  was	  controlled	  for	  in	  all	  de	  novo	  variant	  analyses.	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  PGC=Psychiatric	  Genomics	  Consortium;	  iPSYCH	  Autism=	  The	  Lundbeck	  Foundation	  Initiative	  for	  Integrative	  Psychiatric	  Research	  (iPSYCH)	  Autism	  GWAS;	  ALSPAC=Avon	  Longitudinal	  Study	  of	  Parents	  and	  Children;	  SCDC=	  Social	  and	  Communication	  Disorders	  Checklist;	  IQ=Intelligence	  Quotient;	  SSC	  =	  Simons	  Simplex	  Collection;	  ExAC=	  Exome	  Aggregation	  Consortium.	  	  	  	   	  
	   Data	  source	   N	   Availability	  Primary	  Genetic	  Correlation	  Analyses:	  	  ASDs	  and	  social	  communication	  variation	  in	  the	  population	  
PGC	  Autism	   5,305	  cases;	  5,305	  pseudocontrols	   Summary	  statistics	  publically	  available	  from	  PGC	  website	  iPSYCH	  Autism	   7,783	  ASD	  cases;	  11,359	  matched	  controls	   Pre-­‐publication	  consortium	  data;	  for	  questions	  email	  mjdaly@atgu.mgh.harvard.edu	  and	  anders@biomed.au.dk	  ALSPAC	  -­‐	  SCDC	   5,628	  general	  population,	  mean	  age	  8	  years	   Primary	  data	  accessible	  following	  approved	  application	  to	  ALSPAC	  executive	  committee	  Secondary	  	  	  Genetic	  Correlation	  Analyses	  
Child	  Full	  Scale	  IQ	   12,441	  general	  population	  individuals	   Summary	  statistics	  publically	  available	  from	  Benyamin	  et	  al.	  2014	  	  
De	  novo	  variant	  analyses	   SSC	   2,508	  ASD	  cases;	  1,911	  unaffected	  sibling	  controls	   Phenotypic	  data	  publically	  available	  from	  the	  Simons	  Foundation;	  de	  novo	  variant	  calls	  from	  Iossifov	  2014	  ExAC	   60,706	  individual	  exomes	   Publically	  available	  from	  the	  Exome	  Aggregation	  Consortium	  
Table	  S2.	  Genetic	  correlations	  between	  ASD	  risk	  and	  IQ	  in	  the	  general	  population	  	  	   Constrained	  Intercept	  rg	  (se),	  p	   Intercept	  not	  constrained	  rg	  (se),	  p	  PGC-­‐ASD	  v.	  Child	  IQ	   0.402	  (0.088),	  p=5.273e-­‐06	   0.300	  (0.126),	  p=0.018	  iPSYCH	  ASD	  v.	  Child	  IQ	   0.139	  (0.068),	  p=0.04	   0.168	  (0.100),	  p=0.09	  	   	  
Table	  S3.	  LD	  score	  genetic	  correlation	  estimates	  with	  and	  without	  intercept	  constraint	  	  	   Constrained	  Intercept	  rg	  (se),	  p	   Intercept	  not	  constrained	  	  rg	  (se),	  p	  	  PGC-­‐ASD	  v.	  SCDC	   0.274	  (0.100),	  	  p=0.006	   0.245	  (0.183),	  	  p=0.179	  PGC-­‐ASD	  v.	  PGC-­‐SCZ	   0.202	  (0.040),	  p=5.635e-­‐07	   0.181	  (0.059),	  p=0.002	  PGC-­‐ASD	  v.	  PGC-­‐MDD	   0.139	  (0.082),	  p=0.092	   0.169	  (0.131),	  p=0.196	  PGC-­‐ASD	  v.	  PGC-­‐BPD	   0.087	  (0.058),	  p=0.134	   0.073	  (0.088),	  p=0.406	  iPSYCH	  ASD	  v.	  SCDC	   0.298	  (0.098),	  p=0.002	   0.544	  (0.191),	  p=0.0045	  	  	   	  
Figure	  S1.	  De	  novo	  variant	  continuum	  without	  the	  ExAC	  filter	  	  
	  	  Note:	  p-­‐values	  derived	  from	  poisson	  regression;	  LoF=	  Loss	  of	  Function;	  DCM	  =	  probably	  damaging	  constrained	  missense;	  ExAC=	  Exome	  Aggregation	  Consortium.	  	  	  	  
 	  	  	  	  
